Q92918 (M4K1_HUMAN) Homo sapiens (Human)

Mitogen-activated protein kinase kinase kinase kinase 1 UniProtKBInterProSTRINGInteractive Modelling

833 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

36 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMIN…homo-2-mer7-304
99.29W9D;
Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with sunitinib…homo-2-mer6-302
99.65B49;
HPK1 IN COMPLEX WITH COMPOUND 1homo-2-mer2-294
99.32YK1;
HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with compound 21homo-2-mer1-292
99.31A1A1B;CL;
Crystal structure of HPK1 in complex with ATP analogue (AMPPNP)homo-2-mer2-293
99.31ANP;MG;
Crystal structure of HPK1 in complex with GNE1858homo-2-mer3-293
99.31F97;EDO;MES;
Crystal structure of HPK1 in complex with compound 17homo-2-mer3-293
99.312TR;
Crystal structure of inhibitor GNE-6893 bound to HPK1homo-2-mer3-293
99.31MES;EDO;DMS;A1APR;NA;PEG;A1APQ;
Crystal structure of HPK1 in complex with compound 14homo-2-mer3-293
99.32WI;SO4;
Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745homo-2-mer5-294
98.979ID;SO4;
Crystal structure of HPK1 kinase domain S171A mutanthomo-2-mer4-293
99.65
Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R…homo-2-mer3-292
99.31Y3I;
HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with compound 53homo-2-mer4-293
99.3A1A1A;
Crystal structure of inhibitor 1 bound to HPK1homo-2-mer4-293
99.64EDO;A1APO;
HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with compound 13homo-2-mer5-293
99.31A1A1C;
HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with compound 6homo-2-mer5-293
99.31A1A1E;
HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with compound 9homo-2-mer5-293
99.31SO4;A1A1D;
HPK1 IN COMPLEX WITH COMPOUND 1homo-2-mer6-294
99.31YK7;
Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(2S…homo-2-mer4-292
99.31Y3O;
HPK1 IN COMPLEX WITH COMPOUND 1homo-2-mer6-294
99.31YK4;
CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 7-(1-methyl-1H-pyrazol-4-yl)-N-[4-(1-methylpi…homo-2-mer7-294
99.3UES;
Crystal structure of HPK1 in complex an inhibitor G1858homo-2-mer6-293
99.64F97;
Crystal structure of inhibitor GNE-6893 bound to HPK1homo-2-mer6-293
99.31A1APL;DMS;NA;
Crystal structure of diphosphorylated HPK1 kinase domain in complex with sunitinib in the active st…homo-2-mer5-292
100.0B49;
Crystal structure of HPK1 in complex with compound 2homo-2-mer7-293
100.02YE;
Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactiv…homo-2-mer10-292
100.0B49;
Crystal structure of HPK1 citron-homology domainmonomer485-799
100.0PO4;
Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-[6-chlo…monomer4-293
99.31XXF;
HPK1 IN COMPLEX WITH COMPOUND 18monomer7-294
99.31XHS;EDO;
Crystal structure of human MAP4K1 with an inhibitor, BAY-405monomer7-294
100.0GOL;XON;
Crystal structure of MAP4K1 with a SMOL inhibitormonomer8-295
100.0XOH;
Crystal structure of MAP4K1 with a SMOL inhibitormonomer7-294
100.0XOR;
HPK1 IN COMPLEX WITH COMPOUND 38monomer8-294
99.29XHM;
Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with compound …monomer6-292
99.3A1LVT;
HPK1 IN COMPLEX WITH COMPOUND 11monomer7-293
99.29XHV;
CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 2-[8-Amino-7-fluoro-6-(8-methyl-2,3-dihydro-1…monomer14-294
99.62USF;

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8eec.1.Amonomer0.78485-815
95.52
6nfz.1.Bmonomer0.785-292
B49;100.00

2 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28eec.1.Amonomer0.83485-820
99.71
Isoform 26nfz.1.Bmonomer0.785-292
B49;100.00